Executive record

Dennis Huang

Chief Technical Operations Officer and Gene Therapy and Executive Vice President at Ultragenyx Pharmaceutical Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:dennis-huangVersion: public-0As of: 2026-09-29

Not yet claimed7 published Claims2 sources
  • Executive

Key Claims

Biography

Mr. Huang has served as Executive Vice President since January 2016 and Chief Technical Operations Officer since May 2015, with prior roles as SVP of Manufacturing and Supply Chain at InterMune and VP of Biologic Manufacturing and Development at Allergan. He holds a B.A. in Chemistry from Knox College.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Technical Operations Officer and Gene Therapy and Executive Vice President · Ultragenyx Pharmaceutical Inc.
  2. 2026 to end not publishedExecutive title: Chief Technical Operations Officer and Gene Therapy and Executive Vice President · Organization not publishedRARE DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. RARE DEF 14A executive officers

    sec filing · Source published: Mar 27, 2026 · Retrieved: May 5, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Ultragenyx Pharmaceutical Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Technical Operations Officer and Gene Therapy and Executive Vice President · Claim reviewed: May 5, 2026
    • Other Company Role: Dennis Huang is also linked to CytoDel, Inc. as Board of Directors Member. · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Mar 27, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: Chief Technical Operations Officer and Gene Therapy and Executive Vice President at Ultragenyx Pharmaceutical Inc. · Claim reviewed: Sep 12, 2026